(BIOG-B) BioGaia (publ) - Performance -11.7% in 12m
BIOG-B performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
11.99%
#27 in Peer-Group
Rel. Strength
28.62%
#5434 in Stock-Universe
Total Return 12m
-11.68%
#69 in Peer-Group
Total Return 5y
17.32%
#37 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 32.7 |
| P/E Forward | - |
| High / Low | SEK |
|---|---|
| 52 Week High | 130.65 SEK |
| 52 Week Low | 93.45 SEK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 62.51 |
| Buy/Sell Signal +-5 | 0.67 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BIOG-B (-11.7%) vs XBI (-7.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
10.4% | 76.6% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.77% | -4.62% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
9.62% | 0.48% | 57% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
2.27% | 33.8% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.43% | -8.06% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
13.1% | 44.8% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
0.29% | 36.9% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.57% | 17.2% | 11.2% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: BIOG-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BIOG-B
| Total Return (including Dividends) | BIOG-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.23% | 7.76% | 1.11% |
| 3 Months | -10.64% | -5.31% | 5.58% |
| 12 Months | -11.68% | -7.58% | 10.51% |
| 5 Years | 17.32% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | BIOG-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -30% | 84.2% | 69.9% |
| 3 Months | -34.1% | -2.8% | 69.3% |
| 12 Months | -51.7% | -77.8% | 43.2% |
| 5 Years | 55% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #142 | -8.34% | -2.31% |
| 3 Month | #112 | -5.64% | -15.37% |
| 12 Month | #69 | -4.44% | -20.08% |
| 5 Years | #35 | 44.04% | -43.90% |
FAQs
Does BioGaia (publ) (BIOG-B) outperform the market?
No,
over the last 12 months BIOG-B made -11.68%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%.
Over the last 3 months BIOG-B made -10.64%, while XBI made -5.31%.
Performance Comparison BIOG-B vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BIOG-B vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.8% | -2.3% | -1.9% | -22% |
| US NASDAQ 100 | QQQ | 1.1% | -2.7% | -1.1% | -21% |
| German DAX 40 | DAX | 3.1% | -0.5% | -18.2% | -41% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.1% | -0.3% | -3.7% | -23% |
| Hongkong Hang Seng | HSI | 0.3% | -6.3% | -20.9% | -39% |
| India NIFTY 50 | INDA | 2.6% | 0.1% | -0.9% | -10% |
| Brasil Bovespa | EWZ | -1.5% | -1.7% | -22.1% | -21% |
BIOG-B vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.2% | -2.7% | -4.7% | -34% |
| Consumer Discretionary | XLY | 1.4% | 0.6% | 8% | -29% |
| Consumer Staples | XLP | 1.2% | -1% | -3.4% | -19% |
| Energy | XLE | -5% | -4.1% | -5.5% | -15% |
| Financial | XLF | 2.4% | 1.3% | -4.7% | -35% |
| Health Care | XLV | -1.1% | -5.6% | -1.4% | -7% |
| Industrial | XLI | 1.9% | -1.6% | -7.4% | -30% |
| Materials | XLB | 1.5% | -2.6% | -2.7% | -11% |
| Real Estate | XLRE | 0.3% | -2.2% | -2.9% | -25% |
| Technology | XLK | 0.5% | -3.2% | -2.3% | -16% |
| Utilities | XLU | -0.5% | -1.8% | -10.2% | -33% |
| Aerospace & Defense | XAR | 1.8% | -7% | -18.8% | -54% |
| Biotech | XBI | 1.2% | -9% | 8.9% | -4% |
| Homebuilder | XHB | 2.5% | 3.8% | 13.5% | -2% |
| Retail | XRT | 4.8% | -1.1% | 6.1% | -12% |
BIOG-B vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -11% | -19.9% | -11.7% | -15% |
| Natural Gas | UNG | 1.6% | 1.4% | -20.2% | 3% |
| Gold | GLD | -2.8% | -7.4% | -32% | -59% |
| Silver | SLV | 1.7% | -12.6% | -21.5% | -34% |
| Copper | CPER | 3.4% | -2.9% | -16.8% | -20% |
BIOG-B vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.7% | -1.9% | -0.4% | -8% |
| iShares High Yield Corp. Bond | HYG | 0.4% | -1.7% | -5.6% | -21% |